Sovereign s Capital Management LLC Makes New $1.71 Million Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Sovereign s Capital Management LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 73,516 shares of the company's stock, valued at approximately $1,706,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp bought a new position in shares of Option Care Health during the fourth quarter valued at approximately $26,000. UMB Bank n.a. grew its stake in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the period. Signaturefd LLC grew its stake in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC grew its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the period. Finally, Johnson Financial Group Inc. purchased a new stake in Option Care Health in the fourth quarter worth $47,000. Institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of several recent research reports. Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, JMP Securities reissued a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Price Performance

NASDAQ:OPCH traded down $0.68 during trading hours on Thursday, reaching $32.03. The stock had a trading volume of 1,110,277 shares, compared to its average volume of 1,859,697. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a 50 day moving average price of $33.09 and a two-hundred day moving average price of $29.17. The stock has a market capitalization of $5.24 billion, a PE ratio of 26.92, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.26 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.